V. I. Kazei

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The substituted carbazole drug PLX01107 is being developed for the treatment of invasive pulmonary aspergillosis. A synthetic method for PLX01107 drug substance was developed in order to produce the required amount of drug substance of a quality suitable to support preclinical trials. An analytical method using HPLC-MS/MS was employed to determine the drug(More)
  • 1